PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
17-Sep-2024 OrganaBio Expands Cell and Gene Therapy Donor Base to Include Patients with Lupus, Other Autoimmune Diseases OrganaBio
17-Sep-2024 ScaleReady announces a G-Rex® Grant has been awarded to Verismo Therapeutics Verismo Therapeutics
17-Sep-2024 AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer’s Disease AC Immune SA
17-Sep-2024 ImmunOs Therapeutics AG Raises $11 Million and Further Strengthens Investor Base ImmunOs Therapeutics
16-Sep-2024 Refeyn establishes new mass photometry Scientific Advisory Board to maximize potential of transformative technology Refeyn Ltd
16-Sep-2024 AAVantgarde announces first patient dosed in First-In-Human Phase 1/2 LUCE-1 study, evaluating AAVB-081 (Dual-AAV) in retinitis pigmentosa related to Usher Syndrome type 1B AAVantgarde Bio
16-Sep-2024 Certa Therapeutics Announces International Non-Proprietary Name for its First-in-class GPR68 Inhibitor Asengeprast (FT011) Certa Therapeutics
16-Sep-2024 Inauguration of the New Richter BioLogics cGMP Facility for the Manufacture of Biopharmaceuticals for the Global Market Richter BioLogics GmbH & Co KG
16-Sep-2024 Transgene and BioInvent’s Oncolytic Virus BT-001 Shows Promising Antitumor Activity in Ongoing Phase I/IIa Trial in Solid Tumors that Failed Previous Treatments Transgene
12-Sep-2024 Alchemab appoints Co-Founder Jane Osbourn as Chief Executive Officer Alchemab
12-Sep-2024 Life science startups can ignite business growth through Discovery Spark Discovery Park
12-Sep-2024 Biocomposites to distribute its NanoBone® product range in the UK Biocomposites
12-Sep-2024 Arctoris acquires Eli Lilly ‘Life Science Studio’ laboratory Arctoris
12-Sep-2024 Vapourtec invests in future with Bristol CDT partnership Vapourtec
12-Sep-2024 QL Biopharm Presented Results from Phase 1c Clinical Study on its Novel Once-Monthly GLP-1RA ZT002 at EASD 2024 Beijing QL Biopharmaceutical Co., Ltd
11-Sep-2024 EASD 2024 | HighTide Therapeutics Presents Oral Reports of Phase 2 Studies HighTide Therapeutics Inc.
10-Sep-2024 Brightflow SAS Raises €16.5M in Series A Financing Round Andrew Lloyd Associates
10-Sep-2024 CD Formulation Launches Special Back to School Promotion for 2024 - Up to 10% Off CD Formulation
09-Sep-2024 Provepharm launches Blumyne™ surgical dye in UK Andrew Lloyd Associates
09-Sep-2024 DiogenX welcomes Eleanor L. Ramos as independent member of its Board of Directors Andrew Lloyd Associates